Has Ashutosh Kumar received payments from drug or device companies?

Yes. Drug and device makers reported $306,712 in general payments to Ashutosh Kumar across 257 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ashutosh Kumar did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ashutosh Kumar come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ashutosh Kumar

Neurodevelopmental Disabilities · Hershey, PANPI 1912343252

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Sarepta Therapeutics, Inc. at 37.5% of the total. 2025 is the largest year on record at $83,167, more than ten times the $6,074 reported in 2019.

$306,712in general payments, 2019–2025

Across 257 payments — averaging $1193.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sarepta Therapeutics, Inc.$115K
PTC Therapeutics, Inc.$99K
ITF Therapeutics LLC$61K
Genentech USA, Inc.$12K
Catalyst Pharmaceuticals, Inc.$5K
Pfizer$5K
plus $9K from 4 others

$249,911in research payments, 2019–2025

Across 109 payments — averaging $2292.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sarepta Therapeutics, Inc.$106K
Janssen Research & Development, LLC$50K
Genentech, Inc.$37K
Novartis$28K
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$28K

What the payments were for

Consulting fees$139,86646%
Speaking & faculty fees$131,70943%
Travel & lodging$30,64610%
Food & beverage$4,4831%
Education$80%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sarepta Therapeutics, Inc.	86	$115,033
PTC Therapeutics, Inc.	102	$98,866
ITF Therapeutics LLC	40	$61,497
Genentech USA, Inc.	11	$11,724
Catalyst Pharmaceuticals, Inc.	7	$5,222
Pfizer	4	$4,936
F. Hoffmann-la Roche AG	1	$3,300
Biogen	2	$3,024
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)	1	$2,100
Livanova USA, Inc.	3	$1,010

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Elevidys$21,757
EVRYSDI$15,024
AGAMREE$4,937
SPINRAZA$2,964
ZOLGENSMA$2,100
VNS Therapy$1,010
EMFLAZA$234

How this compares

Too few neurodevelopmental disabilities providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Other neurodevelopmental disabilities in Hershey

Sita PaudelHershey$808
Gozde ErdemirHershey$729
Sunil NaikHershey$497
William TrescherHershey$142
Doo ChoJohnstown$9K
Kate KieltyPittsburgh$134
Thomas CaseyBryn Mawr$94

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →